BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3670445)

  • 1. [Behçet's disease].
    Stokvis JC
    Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1585-6. PubMed ID: 3670445
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cyclosporin A in the treatment of uveitis in Behçet's disease: apropos of a case].
    Annonier P; Brini A
    Bull Soc Ophtalmol Fr; 1986 Mar; 86(3):305-8. PubMed ID: 3802341
    [No Abstract]   [Full Text] [Related]  

  • 3. Short term cyclosporin A treatment of Behçet's disease.
    Müftüoğlu AU; Pazarli H; Yurdakul S; Yazici H; Ulkü BY; Tüzün Y; Serdaroğlu S; Altuğ E; Bahçecioğlu H; Güngen G
    Br J Ophthalmol; 1987 May; 71(5):387-90. PubMed ID: 3580358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of the ocular form of Behçet disease with cyclosporin A].
    Pahlitzsch T; Wyrobisch W; Kämpe C; Wiederholt M
    Klin Monbl Augenheilkd; 1990 Jun; 196(6):466-9. PubMed ID: 2376943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A in the treatment of posterior uveitis.
    Graham EM; Sanders MD; James DG; Hamblin A; Kasp Grochowska E; Dumonde D
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():146-51. PubMed ID: 3857775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment.
    Yamada Y; Sugita S; Tanaka H; Kamoi K; Takase H; Mochizuki M
    Br J Ophthalmol; 2011 Feb; 95(2):205-8. PubMed ID: 20542984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of infliximab on refractory uveitis in Behcet's disease.
    Sayarlioglu M; Cinal A; Topcu N; Demirok A
    Ann Pharmacother; 2004 May; 38(5):901-2. PubMed ID: 15010522
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of refractory Behçet's disease with cyclosporin A].
    Masuda K
    Kango Gijutsu; 1985 Mar; 31(4):522-3. PubMed ID: 3846677
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicenter clinical open trial of FK 506 in refractory uveitis, including Behçet's disease. Japanese FK 506 Study Group on Refractory Uveitis.
    Mochizuki M; Masuda K; Sakane T; Inaba G; Ito K; Kogure M; Sugino N; Usui M; Mizushima Y; Ohno S
    Transplant Proc; 1991 Dec; 23(6):3343-6. PubMed ID: 1721456
    [No Abstract]   [Full Text] [Related]  

  • 10. Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease.
    Rosenbaum JT
    J Rheumatol; 2004 Jul; 31(7):1241-3. PubMed ID: 15229938
    [No Abstract]   [Full Text] [Related]  

  • 11. [Value and complications of immunosuppressive therapy in uveitis of Behcet's disease or of other etiology. Apropos of 40 cases].
    Niessen F; Campinchi R; Bloch-Michel E
    J Fr Ophtalmol; 1982; 5(6-7):407-16. PubMed ID: 7130629
    [No Abstract]   [Full Text] [Related]  

  • 12. [A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions].
    Sakane T; Mochizuki M; Inaba G; Masuda K
    Ryumachi; 1995 Oct; 35(5):802-13. PubMed ID: 8594659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclosporin A treatment of Behçet's disease].
    Büsch R; Ruzicka T; Donhauser G
    Hautarzt; 1990 Apr; 41(4):229-31. PubMed ID: 2358347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation criteria for uveitis in Behçet's syndrome].
    Hamza M; Ouertani A
    Rev Rhum Ed Fr; 1993 Apr; 60(4):315-6. PubMed ID: 8167635
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-a (IFN-a) application versus tumor necrosis factor-a antagonism for ocular Behçet's disease: focusing more on IFN.
    Kotter I; Deuter C; Stubiger N; Zierhut M
    J Rheumatol; 2005 Aug; 32(8):1633; author reply 1634. PubMed ID: 16078350
    [No Abstract]   [Full Text] [Related]  

  • 16. Behçet's syndrome.
    O'Duffy JD
    N Engl J Med; 1990 Feb; 322(5):326-8. PubMed ID: 2404205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of skin symptoms of Behçet's disease with low dose cyclosporin A].
    Iiyoshi E; Takahashi Y; Sasaki T; Nakajima H
    Nihon Hifuka Gakkai Zasshi; 1989 Jul; 99(8):877-81. PubMed ID: 2585781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of cyclosporin therapy for Behçet's disease.
    Nussenblatt RB; Palestine AG; Chan CC; Mochizuki M; Yancey K
    Arthritis Rheum; 1985 Jun; 28(6):671-9. PubMed ID: 4004976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin in Behçet's disease.
    Lancet; 1983 Aug; 2(8347):454-5. PubMed ID: 6135934
    [No Abstract]   [Full Text] [Related]  

  • 20. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
    Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.